FDA Explores Over-the-Counter ADHD Medication
The U.S. Food and Drug Administration is pursuing an initiative to make more drugs available over the counter, potentially including some ADHD medications. However, some experts have raised safety concerns, citing risks of misuse and the necessity of professional oversight, particularly for pediatric and adolescent populations.
- The FDA's general initiative to move more drugs from prescription to over-the-counter (OTC) requires manufacturers to prove a drug is safe and effective for consumers to use without a healthcare professional's supervision. This involves a rigorous review of a drug's toxicity, potential for harmful effects, and the ability of consumers to self-diagnose the condition and use the medication correctly. - For a medication to be switched to OTC status, it must have a well-established safety profile and a low potential for misuse and abuse. This presents a significant hurdle for stimulant ADHD medications like Adderall or Ritalin, which are classified as controlled substances due to their potential for dependence and misuse. - Non-stimulant ADHD medications could be more likely candidates for an OTC switch as they are not controlled substances and have a lower risk of abuse. These drugs, such as atomoxetine (Strattera) and viloxazine (Qelbree), work by increasing the amount of the neurotransmitter norepinephrine in the brain. - A key challenge for any potential OTC ADHD medication is the necessity of an accurate diagnosis, which typically involves a comprehensive evaluation by a healthcare professional. There are concerns about the risks of misdiagnosis and the inappropriate use of these medications by individuals who do not have ADHD. - While no specific pharmaceutical ADHD medications have been publicly announced as candidates for an OTC switch, the FDA has approved a digital therapeutic, EndeavorOTC, as an over-the-counter treatment for adults with ADHD. This treatment is delivered through a video game and is designed to improve attention function. - The process for switching a drug to OTC can be either a "full switch," where the medication becomes entirely nonprescription, or a "partial switch," where certain doses or indications are available OTC while others remain prescription-only. - Should a manufacturer seek an OTC switch for an ADHD medication, they would need to conduct extensive studies, including label comprehension and actual use studies, to demonstrate that consumers can appropriately self-select and use the product.
